Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Scynexis Inc (SCYX)

Scynexis Inc (SCYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
SCYNEXIS Initiates Dosing in Phase 1 Trial of SCY-247, a Second-Generation Fungerp Candidate for Invasive Fungal Infections GlobeNewswire - Wed Dec 18, 7:00AM CST

SCYX : 1.0200 (+2.01%)
Scynexis: Q3 Earnings Snapshot AP - Wed Nov 6, 4:55PM CST

Scynexis: Q3 Earnings Snapshot

SCYX : 1.0200 (+2.01%)
SCYNEXIS Reports Third Quarter 2024 Financial Results and Provides Corporate Update GlobeNewswire - Wed Nov 6, 3:30PM CST

SCYX : 1.0200 (+2.01%)
SCYNEXIS to Participate in the 2024 Maxim Healthcare Virtual Summit GlobeNewswire - Thu Oct 10, 7:00AM CDT

SCYX : 1.0200 (+2.01%)
SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at IDWeek 2024 GlobeNewswire - Thu Oct 3, 7:00AM CDT

SCYX : 1.0200 (+2.01%)
Scynexis: Q2 Earnings Snapshot AP - Thu Aug 8, 4:44PM CDT

Scynexis: Q2 Earnings Snapshot

SCYX : 1.0200 (+2.01%)
Scynexis: Q1 Earnings Snapshot AP - Wed May 8, 3:51PM CDT

Scynexis: Q1 Earnings Snapshot

SCYX : 1.0200 (+2.01%)
Scynexis: Q3 Earnings Snapshot AP - Mon Nov 13, 2023

Scynexis: Q3 Earnings Snapshot

SCYX : 1.0200 (+2.01%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SCYNEXIS, Inc. - SCYX PR Newswire - Tue Oct 17, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of SCYNEXIS, Inc. ("SCYNEXIS" or the "Company") (NASDAQ: SCYX). Such investors are...

SCYX : 1.0200 (+2.01%)
The Law Offices of Frank R. Cruz Announces Investigation of SCYNEXIS, Inc. (SCYX) on Behalf of Investors PR Newswire - Fri Oct 6, 2023

/PRNewswire/ -- The Law Offices of Frank R. Cruz announces an investigation of SCYNEXIS, Inc. ("SCYNEXIS" or the "Company") (NASDAQ: SCYX) on behalf of...

SCYX : 1.0200 (+2.01%)

Barchart Exclusives

3 Pharma Stocks to Buy as California Sounds the Alarm on Bird Flu Cases Barchart - 1 hour ago
The bird flu crisis is creating investment opportunities in the pharmaceutical sector, with Sanofi, GSK, and CSL Limited emerging as top picks. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot